Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Long-Term Safety, Tolerability, And Efficacy of Efgartigimod in Patients with Generalized Myasthenia Gravis: Concluding Analyses from the ADAPT+ Study